ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.445
+0.075 (5.47%)
Jul 24, 2026, 5:24 PM CET

STO:EXPRS2 Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-43.55-44.27-67.7-105.97-127.61-48.4
Other Adjustments
2.032.41.375.319.9912.29
Change in Receivables
-8.040.97-2.058.63-8.19-1.35
Changes in Accounts Payable
-4.6-8.1226.29-17.3222.6-10.99
Changes in Income Taxes Payable
8.118.118.158.473.592.8
Operating Cash Flow
-46.05-40.9-33.93-100.89-99.61-45.65
Capital Expenditures
---0.87-2.02-0.38-0.72
Purchases of Intangible Assets
-----0.05
Other Investing Activities
--22.150105.71-100.25
Investing Cash Flow
-021.28-2.02105.33-100.92
Long-Term Debt Issued
----3.86-1.79-1.36
Net Long-Term Debt Issued (Repaid)
----3.86-1.79-1.36
Issuance of Common Stock
11.2611.2634.9950.2463.7876.53
Net Common Stock Issued (Repurchased)
11.2611.2634.9950.2463.7876.53
Other Financing Activities
-0.62-0.48-0.121.47-0.52-0.62
Financing Cash Flow
10.6410.7834.8747.8461.4674.55
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.75-3.861.731.696.692.3
Net Cash Flow
-35.41-30.1222.22-55.0767.17-72.02
Free Cash Flow
-46.05-40.9-34.8-102.9-100-46.36
FCF Margin
-285.69%-335.09%-444.70%-1169.47%-1625.97%-337.66%
Free Cash Flow Per Share
-3.39-14.38-20.58-89.22-113.99-63.42
Levered Free Cash Flow
-32.73-38.09-2.47-106.14-94.59-54.19
Unlevered Free Cash Flow
-32.96-38.17-21.17-107.76-93.76-53.65